FLGC logo

Flora Growth Stock Price

Symbol: NasdaqCM:FLGCMarket Cap: US$11.4mCategory: Household

FLGC Share Price Performance

US$19.19
-18.20 (-48.68%)
87.7% undervalued intrinsic discount
US$156.00
Fair Value
US$19.19
-18.20 (-48.68%)
87.7% undervalued intrinsic discount
US$156.00
Fair Value
Price US$19.19
AnalystConsensusTarget US$156.00

FLGC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$156.00 87.7% undervalued intrinsic discount

US Cannabis And European Beverage Markets Will Create Opportunities

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative

Recent FLGC News & Updates

No updates

Flora Growth Corp. Key Details

US$52.4m

Revenue

US$41.2m

Cost of Revenue

US$11.2m

Gross Profit

US$24.3m

Other Expenses

-US$13.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-22.60
Gross Margin
21.37%
Net Profit Margin
-24.96%
Debt/Equity Ratio
123.7%

Flora Growth Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About FLGC

Founded
2019
Employees
70
CEO
Clifford Starke
WebsiteView website
www.floragrowth.com

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

U.S. Market Performance

  • 7 Days: -1.2%
  • 3 Months: 12.3%
  • 1 Year: 21.3%
  • Year to Date: 7.0%
In the last week, the market has fallen 1.2%, dragged down most by the Consumer Discretionary. As for the longer term, the market has actually risen by 21% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading